6.18
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significa…
Various factors impact a drug's renal clearance, including its physical-chemical properties and plasma levels.
Molecular size, lipid solubility, and stereoselectivity influence clearance.
Molecules below 300 Daltons are readily excreted.
Molecules weighing between 300 to 500 Daltons are excreted in urine and bile, while those above 500 Daltons are excreted less in urine.
Lipophilic drugs are passively reabsorbed and exhibit an inverse relationship with urinary excretion.
Stereoselectivity, especially in protein-bound drugs, affects filtration rates for enantiomers.
It is also observed for active tubular secretion and reabsorption, as seen in chloroquine and glucose.
Renal clearance is also affected by plasma drug concentration.
Non-protein bound drugs eliminated by filtration show a linear relationship between excretion rate and plasma drug concentration.
Actively reabsorbed drugs are excreted when their concentration exceeds the active reabsorption capacity.
Actively secreted drugs exhibit increasing excretion rates until saturation occurs.
Understanding these factors is crucial for optimizing therapeutic strategies.
View the full transcript and gain access to JoVE Core videos
Q1: How does molecular size affect a drug's renal clearance?
Molecular size significantly influences renal clearance. Molecules below 300 Daltons are readily excreted by the kidneys. Molecules between 300 and 500 Daltons are excreted through both urine and bile. Larger molecules above 500 Daltons are excreted less efficiently in urine, resulting in reduced renal clearance.
Q2: Why do lipophilic drugs show lower urinary excretion rates?
Lipophilic drugs have high affinity for fatty tissues and undergo passive reabsorption in the renal tubules. This reabsorption decreases the amount of drug excreted in urine, creating an inverse relationship between lipid solubility and urinary excretion. The more lipophilic a drug is, the greater its reabsorption and the lower its renal clearance.
Q3: What role does stereoselectivity play in renal drug clearance?
Stereoselectivity affects renal clearance, particularly for protein-bound drugs and their enantiomers—mirror-image molecules with identical chemical compositions but different spatial arrangements. The kidneys may exhibit different filtration rates for these enantiomers, leading to variations in their renal clearance. This selectivity also influences active tubular secretion and reabsorption processes.
Q4: How does plasma drug concentration affect the excretion of non-protein-bound drugs?
Non-protein-bound drugs eliminated by glomerular filtration show a linear relationship between excretion rate and plasma drug concentration. As plasma concentration increases, the excretion rate increases proportionally. This direct relationship continues as long as the filtration capacity is not exceeded by the drug.
Q5: What happens when actively reabsorbed drugs exceed their reabsorption capacity?
Actively reabsorbed drugs are excreted when their plasma concentration exceeds the maximum reabsorption capacity of the renal tubules. Below this threshold, the drugs are reabsorbed back into the bloodstream. Once the saturation point is surpassed, excess drug is eliminated in urine, increasing renal clearance.
Q6: How do actively secreted drugs respond to increasing plasma concentrations?
Actively secreted drugs exhibit increasing excretion rates as plasma concentration rises, until saturation occurs. Once the active secretion mechanism reaches its maximum capacity, further increases in drug concentration do not result in higher excretion rates. This saturation point is critical for predicting drug elimination at high concentrations.
Q7: Why is understanding renal clearance factors important for drug therapy?
Understanding factors affecting renal clearance is crucial for optimizing therapeutic strategies and ensuring effective drug dosing. Knowledge of how physicochemical properties and plasma levels influence clearance allows clinicians to predict drug elimination rates, adjust doses appropriately, and avoid toxic accumulation or subtherapeutic levels.